FDC informed that the drug maker has received final approval from United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Cefixime 400 mg tablets.
Superbugs, bacteria that are immune to multiple antibiotics, pose a great challenge to modern medicine. Researchers have now identified a weakness in the bacterial machinery that drives antibiotic ...